Walleye Capital’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-91,935
| Closed | -$2.67M | – | 2296 |
|
|
2024
Q4 | $2.67M | Buy |
+91,935
| New | +$2.67M | 0.01% | 600 |
|
|
2023
Q4 | – | Sell |
-123,220
| Closed | -$786K | – | 2863 |
|
|
2023
Q3 | $786K | Buy |
123,220
+110,885
| +899% | +$707K | ﹤0.01% | 978 |
|
|
2023
Q2 | $137K | Buy |
+12,335
| New | +$137K | ﹤0.01% | 1426 |
|
|
2022
Q4 | – | Sell |
-270,907
| Closed | -$4.42M | – | 2536 |
|
|
2022
Q3 | $4.42M | Sell |
270,907
-1,399
| -0.5% | -$22.8K | 0.08% | 240 |
|
|
2022
Q2 | $3.96M | Buy |
272,306
+132,671
| +95% | +$1.93M | 0.11% | 201 |
|
|
2022
Q1 | $2.58M | Buy |
+139,635
| New | +$2.58M | 0.07% | 283 |
|